Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1, Multicenter Trial of Subcutaneous Trastuzumab Deruxtecan in Participants With Metastatic Solid Tumors

NCT07015697 is registered in ClinicalTrials.gov with Daiichi Sankyo as lead sponsor.

NCT NCT07015697
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07015697 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1, Multicenter Trial of Subcutaneous Trastuzumab Deruxtecan in Participants With Metastatic Solid Tumors
Lead sponsor
Daiichi Sankyo
Phase
Phase 1
Overall status
Recruiting
Start date
July 17, 2025
Completion date
December 31, 2028
Enrollment
76 (estimated)
Sites
31

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent or metastatic solid tumors